1. Home
  2. REPL vs LPTH Comparison

REPL vs LPTH Comparison

Compare REPL & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$1.79

Market Cap

692.8M

Sector

Health Care

ML Signal

HOLD

Logo LightPath Technologies Inc.

LPTH

LightPath Technologies Inc.

HOLD

Current Price

$14.29

Market Cap

563.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
REPL
LPTH
Founded
2015
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
692.8M
563.1M
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
REPL
LPTH
Price
$1.79
$14.29
Analyst Decision
Buy
Strong Buy
Analyst Count
9
3
Target Price
$11.00
$13.33
AVG Volume (30 Days)
2.4M
1.8M
Earning Date
05-21-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
5.25
N/A
EPS
N/A
N/A
Revenue
N/A
$37,202,630.00
Revenue This Year
N/A
$83.04
Revenue Next Year
N/A
$24.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.26
52 Week Low
$2.68
$1.85
52 Week High
$13.24
$15.24

Technical Indicators

Market Signals
Indicator
REPL
LPTH
Relative Strength Index (RSI) 19.65 66.61
Support Level N/A $9.60
Resistance Level $8.82 $15.24
Average True Range (ATR) 0.83 1.14
MACD -0.48 0.35
Stochastic Oscillator 4.01 92.29

Price Performance

Historical Comparison
REPL
LPTH

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

About LPTH LightPath Technologies Inc.

LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.

Share on Social Networks: